The US Bankruptcy Court granted an order for the appointment of Trustee for the Chapter 11 bankruptcy case of HTG Molecular Diagnostics, Inc. on July 21, 2023. Chris Linscott has been appointed as the Chapter 11 Trustee by the US trustee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | -.--% | -.--% | +92.31% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+92.31% | 5.54K | |
-26.26% | 16.26B | |
-50.54% | 2.44B | |
+25.26% | 1.98B | |
-8.81% | 1.52B | |
+28.12% | 1.3B | |
-18.54% | 937M | |
-32.14% | 775M | |
-1.69% | 760M | |
-26.54% | 615M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.